NEUP
Financials
- Market Capitalization 20.32 M
- Employee 8
- Founded 1996
- CEO N/A
- Website www.neuphoriatx.com
- Headquarter Australia
- FIGI BBG01RFZ8658
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4551 |  COCP Cocrystal Pharma, Inc. - Common Stock | 1.10 USD | -3.51% | -7.56% | +26.44% | -29.03% | 21.19 M USD | ||
| 4558 |  AKTX Akari Therapeutics Plc - American Depositary Shares | 10.70 USD | +18.76% | +33.75% | +33.75% | +1289.61% | 20.83 M USD | ||
| 4579 |  CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.71 USD | -0.37% | +23.74% | +77.12% | +83.73% | 19.49 M USD | ||
| 4590 |  RADX Radiopharm Theranostics Limited American Depositary Shares | 2.41 USD | +6.64% | -0.82% | -23.49% | -56.18% | 19.00 M USD |
Frequently asked questions about Neuphoria Therapeutics Inc. Common Stock
What is the Neuphoria Therapeutics Inc. Common Stock stock price today?
The current price of Neuphoria Therapeutics Inc. Common Stock (NEUP) is 3.76. Over the past 24 hours, the stock has changed by -0.27%. Follow the NEUP chart for real-time price dynamics.
What is the stock ticker of Neuphoria Therapeutics Inc. Common Stock?
Neuphoria Therapeutics Inc. Common Stock trades under the ticker NEUP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Neuphoria Therapeutics Inc. Common Stock stock going up?
NEUP has changed by -3.59% over the last week, -1.05% over the last month, and -66.81% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Neuphoria Therapeutics Inc. Common Stock?
Neuphoria Therapeutics Inc. Common Stock currently has a market capitalization of 20.32 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Neuphoria Therapeutics Inc. Common Stock earnings last quarter?
Last quarter, Neuphoria Therapeutics Inc. Common Stock reported earnings of -0.09 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Neuphoria Therapeutics Inc. Common Stock revenue for the last quarter?
Neuphoria Therapeutics Inc. Common Stock reported quarterly revenue of 496.69 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
How many employees does Neuphoria Therapeutics Inc. Common Stock have?
As of the latest available data, Neuphoria Therapeutics Inc. Common Stock has 8 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Neuphoria Therapeutics Inc. Common Stock stock?
You can buy Neuphoria Therapeutics Inc. Common Stock (NEUP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Neuphoria Therapeutics Inc. Common Stock stock?
Investing in Neuphoria Therapeutics Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NEUP chart and related analysis on metatrader.com as part of your research.